HEALTH OF WOMAN.2015.10(106):166–167 

Influence urogenital chlamydial infection in pregnant women on reproductive health 

Vasilyeva K. V., Dudchenko M. O., Popova I. B., Ketova O. M.

Department of internal medicine and medical emergency conditions with dermatology and venerology, «Ukrainian medical stomatological Academy», Poltava

Department of obstetrics and gynecology № 1 of the state Higher educational institution of Ukraine «Ukrainian medical stomatological Academy», Poltava 

Studies of pregnant women for chlamydiasis using an immunoenzyme assay yielded positive reaction in 418 patients (41.62%) Positive results were obtained in 174 (41.62%), confirmed by nucleic acid amplification (PCR diagnostics) in 138 (33.01%) of the total number of surveys. 53.12% of the women included in the study had complicated obstetric and gynecological history while 73.56%were at risk of abortion. Patients offered specific anti – chlamydial therapy suffered a significantly lower incidence of premature delivery and minimal risk of intrauterine and generalized neonatal infection. 

Key words: reproductive health, urogenital infection, chlamydia, pregnancy. 

REFERENCES

1. Land JA, Van Bergen JEAM, Morre SA et al. 2010. Epidemiology of Chlamydia trachomatis infection in women and the costeffectiveness of screening. Human Reproduction Update 16(2):189–204. http://dx.doi.org/10.1093/humupd/dmp035; PMid:19828674

2. WHO. Prevention and control of sexually transmitted infections: draft global strategy, 2006. Available from: http://www.who.int/reproductive-health/docs/stis_strategy.pdf

3. No authors listed. CDC Grand Rounds: Chlamydia. MMWR Morb Mortal Wkly Rep. 60(12):370–373. 2011. PMid:21451447

4. Peipert JF. 2003. Genital chlamydial infections. N Engl J Med. 349:2424–2430. http://dx.doi.org/10.1056/NEJMcp030542; PMid:14681509

5. Lanjouw E, Ossewaarde JM, Stary A et al. 2010. 2010 European guideline for the management of Chlamydia trachomatis infections. Int J STD AIDS. 21(11):729–737. http://dx.doi.org/10.1258/ijsa.2010.010302; PMid:21187352

6. Van de Laar MJ, Morre SA. 2007. Chlamydia: a major challenge for public health. Euro Surveill 1;12(10):1–2.

7. Sutton M, Sternberg M, Zaidi A et al. 2005. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985–2001. Sex Transm Dis. 32:778–784. http://dx.doi.org/10.1097/01.olq.0000175375.60973.cb; PMid:16314776

8. Мавров ИИ. 2009. Актуальные медико – социальные проблемы хламидийной инфекции. Дерматология и венерология 1(11):37-41.

9. Российское общество дерматовенерологов. Инфекции, передаваемые половым путем. Клинические рекомендации. Дерматовенерология. Под ред. АА Кубановой. М, ДЭКС-Пресс. 2010:413–425.

10. Лисеева ЗА, Панкратова ВИ, Потапова ТМ. 2001. Роль хламидийной инфекции в генезе бесплодия. Акуш и гинек. 7:54–59.

11. Boyer CB, Shafer MA, Shaffer RA. 2005. Evaluation of a cognitive-behavioral, group, randomized controlled intervention trial to prevent sexually transmitted infections and unintended pregnancies in young women. Prev Med. 40(4):420–431. http://dx.doi.org/10.1016/j.ypmed.2004.07.004; PMid:15530594

12. Sugiura-Ogasawara MY, Ozaki Р, Nakanishi T et al. 2005. Sugiura-Ogasawara M, Links. Pregnancy outcome in recurrent aborters is not influenced by chlamydia IgA and/or G. Am J Reprod Immunol. 53(1):50–53. http://dx.doi.org/10.1111/j.1600-0897.2004.00242.x; PMid:15667525

13. Sheffield JS, Andrews WW, Klebanoff MA et al. 2005. Links Spontaneous Resolution of Asymptomatic Chlamydia trachomatis in Pregnancy. Obstet Gynecol. 105(3):557–562. http://dx.doi.org/10.1097/01.AOG.0000153533.13658.c2; PMid:15738024